Pharmaceuticals Mexico

Mexico Newborn Genome Sequencing Market Analysis, 2024–2034

Mexico Newborn Genome Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Program, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Mexico · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.5 Mn Estimated value
Estimate 2025 $6.6 Mn 1.5% of the global market
Projected 2034 $34.2 Mn 416% Adds $27.6 Mn over 9 forecast years
CAGR 2025–2034 20.0% Faster than 86% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Mexico is 1.53% of the global market.
  • In Latin America, the largest is Brazil at $12.3 Mn.
  • Fastest growing: Brazil at 20.9% a year.
  • Mexico ranks 3rd of 3 by size in Latin America.

Market size projection

Mexico

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$27.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Newborn Genome Sequencing Market market size by year, Mexico
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.5 Mn — —
2025 (base) $6.6 Mn +$1.1 Mn —
2026 (forecast) $7.9 Mn +$1.3 Mn +20%
2027 (forecast) $9.5 Mn +$1.6 Mn +44%
2028 (forecast) $11.4 Mn +$1.9 Mn +72.8%
2029 (forecast) $13.7 Mn +$2.3 Mn +107.4%
2030 (forecast) $16.5 Mn +$2.7 Mn +148.8%
2031 (forecast) $19.8 Mn +$3.3 Mn +198.6%
2032 (forecast) $23.7 Mn +$4.0 Mn +258.3%
2033 (forecast) $28.5 Mn +$4.7 Mn +330%
2034 (forecast) $34.2 Mn +$5.7 Mn +416%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $432.0 Mn
  2. US $190.9 Mn
  3. North America $184.9 Mn
  4. APAC $96.3 Mn
  5. Europe $89.1 Mn
  6. Canada $36.6 Mn
  7. China $33.1 Mn
  8. Japan $23.5 Mn
  9. Latin America $22.5 Mn
  10. Middle East $15.8 Mn
  11. Germany $13.7 Mn
  12. UK $12.2 Mn
  13. Brazil $12.3 Mn
  14. Italy $11.7 Mn
  15. France $10.8 Mn
  16. Ecuador $9.6 Mn
  17. India $8.6 Mn
  18. Spain $8.0 Mn
  19. Mexico (this report) $6.6 Mn
  20. Saudi Arabia $6.5 Mn
  21. Africa $5.9 Mn
  22. Australia $5.4 Mn
  23. New Zealand $5.1 Mn
  24. Russia $4.3 Mn
  25. South Africa $2.8 Mn
  26. UAE $2.1 Mn
  27. Egypt $1.3 Mn
  28. Philippines $1.0 Mn
  29. Malaysia $0.9 Mn
  30. Hong Kong $0.7 Mn
  31. Thailand $0.6 Mn
  32. Singapore $0.4 Mn
  33. Kenya $0.3 Mn

The Mexico Newborn Genome Sequencing Market Analysis Executive Summary

Newborn genome sequencing reads a baby's DNA to find treatable genetic conditions early, beyond standard newborn screening.

Key segments of the newborn Genome Sequencing market include program (Research Programs, National Screening Pilots and Private Testing) and condition (Metabolic, Immune and Neurological).

Mexico Newborn Genome Sequencing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the newborn Genome Sequencing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the newborn Genome Sequencing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the newborn Genome Sequencing market.

Competitive Landscape for Newborn Genome Sequencing Market in Mexico

The newborn Genome Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Newborn Genome Sequencing Market in Mexico

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for newborn Genome Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Mexico.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Newborn Genome Sequencing right now, from free public sources.

Latest research 53 papers since 2021 (worldwide)

  1. Genomic newborn and population screening: what osteogenesis imperfecta teaches us about the promise and perils of genomic screening. Disease models & mechanisms, 2026
  2. Corrigendum to "Complexity of genomic diagnosis: Lessons learnt from the UK Biobank and Generation study newborn genome sequencing analyses" [Bone 212 (2026) 118009]. Bone, 2026
  3. Selection of Genetic Conditions for Multi-State Genomic Newborn Screening in BRIDGES-NBS. Genetics in medicine : official journal of the American College of Medical Genetics, 2026
  4. Complexity of genomic diagnosis: Lessons learnt from the UK Biobank and Generation study newborn genome sequencing analyses. Bone, 2026
  5. Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions. Annales d'endocrinologie, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Newborn Genome Sequencing in context

Mexico compared

  • Health spending per person: 761 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.59 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 8.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 4 countries we cover in Latin America.[3]

Questions, answered with public data

How much research is published on Newborn Genome Sequencing?
PubMed lists 53 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Newborn Genome Sequencing in Mexico? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Cord Blood Banking: Is It Worth It?Doctors' groups such as ACOG support public cord blood donation, but say routine private banking is not… From Melghat, With Hope: How a Tribal Region is Redefining Newborn CareLow-cost digital tools empower tribal nurses, cutting newborn deaths through innovation
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Mexico

See all
Same topic, other categories

Related on genomics and neonatal

See the topic